Shilajit with Ashwagandha: Synergy, Evidence, and What to Watch For

Shilajit combined with ashwagandha (Withania somnifera) is one of the most common formulations in the Ayurvedic-adjacent supplement market. Both ingredients are classified as adaptogens, both carry testosterone and energy claims, and their traditional association in Ayurvedic medicine gives brands a compelling narrative. But the clinical evidence for the combination specifically is thin — and the dosing practices in most products make the combination unlikely to produce the effects the clinical literature reports for either ingredient individually.

Why Brands Combine Them

The rationale is straightforward: both shilajit and ashwagandha are adaptogens — herbs proposed to help the body modulate its response to physical and psychological stress. Both carry overlapping claims: fatigue reduction, stress support, testosterone support, and physical performance enhancement. Combining them allows a brand to address a broader set of consumer goals with a single SKU, and the Ayurvedic tradition of combining herbs creates a perception of synergy that selling each ingredient separately does not.

Ashwagandha is also significantly cheaper per unit than high-quality purified shilajit resin. A combination formula allows brands to reduce their shilajit cost per capsule while maintaining a compelling ingredient list.

Clinical Evidence for Each Ingredient Separately

Shilajit — testosterone: Pandit et al. (2016) conducted a randomised, double-blind, placebo-controlled trial in 75 healthy male volunteers aged 45–55. Participants received 250 mg of a proprietary standardised shilajit extract (PrimaVie®) twice daily (500 mg/day total) for 90 days. The study found statistically significant increases in total testosterone, free testosterone, and DHEAS compared to placebo. This is the most cited RCT for shilajit and testosterone, and it is critical to note it used a specific proprietary extract at a specific dose — not a generic "shilajit" product.

Ashwagandha — testosterone and physical performance: Wankhede et al. (2015) conducted an 8-week RCT in 57 young male subjects (18–50 years) receiving either 300 mg ashwagandha root extract (KSM-66®) twice daily (600 mg/day total) or placebo. The study found significantly greater increases in muscle strength, recovery, and testosterone compared to placebo. Again, this was a specific branded extract (KSM-66®, standardised to ≥5% withanolides) at a specific dose.

Ashwagandha — stress and cortisol: Salve et al. (2019) ran a 60-day RCT in 60 subjects with chronic stress, using 240 mg/day of a proprietary ashwagandha extract (Shoden®). The study found significant reductions in stress, anxiety, serum cortisol, and improvements in sleep quality compared to placebo.

Evidence for the Combination Specifically

The honest answer here is: very limited. There is no well-powered, independent RCT demonstrating that the combination of shilajit and ashwagandha produces additive or synergistic effects beyond what either ingredient achieves alone.

Some in vitro and animal studies have examined combinations of Ayurvedic herbs in traditional formulations, but these do not constitute clinical evidence for combination products as sold in the US supplement market. The claim that combining these two ingredients produces synergy beyond each ingredient separately is a marketing claim without specific clinical support.

The Dosing Problem: Most Combinations Are Sub-Clinical

This is the most practically important issue. The clinical evidence summarised above used these doses:

A two-capsule serving of a typical combination product might contain 200 mg of shilajit extract and 300 mg of ashwagandha root — with additional ingredients (black pepper extract, zinc, vitamin D, etc.) in the remaining capsule space. Both doses are below the amounts used in the studies that generated the positive testosterone results. Whether sub-clinical doses produce proportionally smaller effects or no measurable effect is not established by the cited literature.

This is not necessarily fraudulent — under-dosed products are common across all supplement categories. But consumers who purchase a combination product believing the clinical evidence translates directly should understand that the evidence was generated using higher doses of specific branded ingredients.

COA Complications for Combination Products

Heavy metals testing is more complex for combination products than for single- ingredient products. The COA must cover the finished blend — because the combination of ingredients, excipients, and potential cross-contamination from blending equipment creates a finished product profile that cannot be predicted from individual ingredient COAs alone.

Many combination product brands provide a COA for the shilajit ingredient only, or for each ingredient separately, without testing the finished capsule. This is insufficient for the same reasons described in our article on pass/fail vs numeric results: the finished product is what the consumer ingests, and it is the only sample that accurately represents their exposure.

The ashwagandha in the combination adds another dimension: ashwagandha root itself can contain withanolides and alkaloids that interact with certain analytical methods, potentially affecting the accuracy of heavy metals measurements if not accounted for in the testing protocol. A credible COA for a shilajit-ashwagandha combination should be generated by a laboratory experienced with complex botanical matrices.

When a Combination Might Make Sense

A shilajit-ashwagandha combination may be worth considering in specific circumstances:

• When the product uses clinically studied branded extracts (PrimaVie® shilajit, KSM-66® or Sensoril® ashwagandha) at doses consistent with the published studies
• When the combination product has a COA for the finished blend from a named, accredited laboratory
• When cost or convenience makes the combination format more practical than two separate products

When these conditions are not met — generic extracts, undisclosed standardisation, sub-clinical doses, or no finished-product COA — taking each ingredient separately with independent COAs gives better control over quality, dosing, and safety verification.